A10AB04 · Alimentary tract and metabolism
Lyumjev (previously Liumjev)
Indications
Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above. Treatment of diabetes mellitus in adults.
Composition
- Active substance
- insulin lispro
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Lyumjev (previously Liumjev)
- Active substance
- insulin lispro
- ATC code
- A10AB04
- Therapeutic area
- Diabetes Mellitus
- Marketing authorisation holder
- Eli Lilly Nederland B.V.
- Status
- Authorised
- EU authorisation
- 24 Mar 2020



